The association between SGLT2 inhibitors and new-onset arrhythmias: a nationwide population-based longitudinal cohort study

BACKGROUND: Clinical trials have shown the cardiovascular protective effect of sodium–glucose cotransporter-2 (SGLT2) inhibitors and reduced hospitalization for heart failure. However, no study has investigated the association between SGLT2 inhibitors and the risk of arrhythmias. This study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hung-Yi, Huang, Jing-Yang, Siao, Wun-Zhih, Jong, Gwo-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275510/
https://www.ncbi.nlm.nih.gov/pubmed/32503541
http://dx.doi.org/10.1186/s12933-020-01048-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275510/
https://www.ncbi.nlm.nih.gov/pubmed/32503541
http://dx.doi.org/10.1186/s12933-020-01048-x

Ejemplares similares